pazufloxacin has been researched along with cilastatin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, H; Kawamura, Y | 1 |
| Fukuda, T; Furuta, Y; Minami, S; Mitsuyama, J; Nakata, M; Nomura, N; Takahata, M; Yamada, H | 1 |
| Akata, K; Fukuda, K; Ishimoto, H; Kato, K; Kawanami, T; Mukae, H; Naito, K; Noguchi, S; Taniguchi, H; Yamasaki, K; Yatera, K | 1 |
3 other study(ies) available for pazufloxacin and cilastatin
| Article | Year |
|---|---|
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
[In vitro and in vivo antibacterial activities of pazufloxacin mesilate, a new injectable quinolone].
Topics: 4-Quinolones; Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; beta-Alanine; Ceftazidime; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Intravenous; Male; Meropenem; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Oxazines; Rats; Thienamycins; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2002 |
Successful Additional Corticosteroid Treatment in a Patient with Mycoplasma pneumoniae Pneumonia in whom a Monobacterial Infection was Confirmed by a Molecular Method Using Bronchoalveolar Lavage Fluid.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cilastatin; Cilastatin, Imipenem Drug Combination; Clindamycin; Disease Progression; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Imipenem; Minocycline; Mycoplasma pneumoniae; Oxazines; Pneumonia, Mycoplasma; Radiography, Thoracic; RNA, Ribosomal, 16S; Treatment Outcome | 2016 |